Concepedia

Author

Christine Boussiquet-Leroux

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

C. Boussiquet-Leroux, C. Boussiquet‐Leroux, Christine Boussiquet-Leroux

6

Publications

137

Citations

4

H-Index

13

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)United States Military AcademyMSD (France)
CB

About

Christine Boussiquet-Leroux is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in urology, physiology, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

29

2

Pharmacology

2

2

29

3

Physiology

2

2

29

4

Nephrology

1

1

10

5

Potassium Homeostasis

1

1

10

Christine Boussiquet-Leroux

×

4

Publications

137

Citations

4

H-Index

YearCitations

The Novel γ Secretase Inhibitor N-[cis-4-[(4-Chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexyl]-1,1,1-trifluoromethanesulfonamide (MRK-560) Reduces Amyloid Plaque Deposition without Evidence of Notch-Related Pathology in the Tg2576 Mouse

Jonathan D. Best, David W. Smith, Michael Reilly,

Journal of Pharmacology and Experimental Therapeutics

2006

83

Evaluation of lymphocyte proliferation by immunohistochemistry in the local lymph node assay

Christine Boussiquet-Leroux, G. Durand‐Cavagna, K. Herlin,

Journal of Applied Toxicology

1995

25

Rat Urinary Bladder Hyperplasia Induced by Oral Administration of Carbonic Anhydrase Inhibitors

Sylvain Molon-Noblot, Christine Boussiquet-Leroux, E. Irisarri,

Toxicologic Pathology

1992

19

Renal Papillary Cytoplasmic Granularity and Potassium Depletion Induced by Carbonic Anhydrase Inhibitors in Rats

G. Durand‐Cavagna, Sylvain Molon-Noblot, Christine Boussiquet-Leroux,

Toxicologic Pathology

1993

10

Page 1